Immediate Impact

1 from Science/Nature 52 standout
Sub-graph 1 of 24

Citing Papers

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
1 intermediate paper

Works of Eisuke Fukuma being referenced

Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
2018

Author Peers

Author Last Decade Papers Cites
Eisuke Fukuma 936 411 307 317 73 1.5k
Mitsuhiro Tozaki 1487 572 323 418 92 2.0k
Ralf Ohlinger 888 393 243 684 82 1.7k
C. Balu–Maestro 904 392 452 501 52 1.7k
Hye Mi Gweon 1052 259 257 540 54 1.5k
Bo La Yun 641 424 228 170 72 1.2k
Steven E. Harms 1102 631 474 162 58 1.9k
Seung Ja Kim 987 400 234 630 39 1.4k
Weiwei Zhan 565 138 218 329 117 1.4k
Fabienne Thibault 944 437 362 233 46 1.4k
Handel Reynolds 469 641 482 300 33 1.4k

All Works

Loading papers...

Rankless by CCL
2026